for the Period Ended 26 June 2023
Balance sheet | |
Notes |
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Fixed assets | |||
Investments: | 3 | | |
Total fixed assets: | | | |
Current assets | |||
Debtors: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | ( | ( | |
Net current assets (liabilities): | ( | ( | |
Total assets less current liabilities: | | | |
Provision for liabilities: | ( | ( | |
Total net assets (liabilities): | | | |
Capital and reserves | |||
Called up share capital: | | | |
Revaluation reserve: | 4 | ||
Profit and loss account: | ( | ( | |
Shareholders funds: | | |
The notes form part of these financial statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 26 June 2023
for the Period Ended 26 June 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period | | |
for the Period Ended 26 June 2023
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
for the Period Ended 26 June 2023
2023 | |
---|---|
£ | |
Balance at 01 July 2022 | |
Surplus or deficit after revaluation | |
Balance at 26 June 2023 |